NLM Digital Collections


Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Languages English Remove constraint Languages: English Copyright Public domain Remove constraint Copyright: Public domain Subjects Centers for Medicare & Medicaid Services (U.S.) Remove constraint Subjects: Centers for Medicare & Medicaid Services (U.S.) Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later
Number of results to display per page

Search Results

1. Medicaid: CMS needs better data to monitor the provision of and spending on personal care services : report to Congressional requesters


2. Medicaid managed care: improved oversight needed of payment rates for long-term services and supports : report to Congressional requesters


4. Medicare provider education: oversight of efforts to reduce improper billing needs improvement : report to the Chairman, Committee on Finance, U.S. Senate


5. Medicaid program integrity: CMS should build on current oversight efforts by further enhancing collaboration with states : report to the Chairman, Committee on Finance, U.S. Senate


6. Health care: telehealth and remote patient monitoring use in Medicare and selected federal programs : report to Congressional committees


7. Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate


8. Medicare advantage: CMS should use data on disenrollment and beneficiary health status to strengthen oversight : report to Congressional Requesters


9. Medicaid personal care services: more harmonized program requirements and better data are needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives


13. The role of ombudsmen in assuring quality for residents of long-term care facilities: straining to make ends meet


14. Hospital value-based purchasing: CMS should take steps to ensure lower quality hospitals do not qualify for bonuses : report to Congressional committees


15. Improper payments: improvements needed in CMS and IRS controls over health insurance premium tax credit : report to Congressional committees


16. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives


17. Medicare: CMS should evaluate providing coverage for disposable medical devices that could substitute for durable medical equipment : report to Congressional committees


18. Medicare Advantage program integrity: CMS's efforts to ensure proper payments and identify and recover improper payments : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives


19. Telehealth: use in Medicare and Medicaid : testimony before the Subcommittee on Agriculture, Energy, and Trade and Subcommittee on Health and Technology, Committee on Small Business, House of Representatives


20. Medicaid: states fund services for adults in institutions for mental disease using a variety of strategies : report to the Co-Chair, Caucus on International Narcotics Control, U.S. Senate


21. Health insurance marketplaces: CMS needs to improve its oversight of state IT systems' sustainability and performance : report to Congressional requesters


22. Medicaid managed care: CMS should improve oversight of access and quality in states' long-term services and supports programs : report to Congressional requesters


23. Medicare: CMS Fraud Prevention System uses claims analysis to address fraud : report to Congressional requesters


24. State health- insurance marketplaces: three states used varied data sources for eligibility and had few indications of potentially improper enrollments : report to Congressional requesters


25. Value-based coverage policy in the United States and the United Kingdom: different paths to a common goal


26. Health care price transparency and price competition


29. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff


30. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace


31. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming


32. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices


33. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS


34. A few states fell short in timely investigation of the most serious nursing home complaints: 2011-2015


35. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices


36. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data


37. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries


38. Followup review: CMS's management of the quality payment program


39. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates


40. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities


41. Opioids in Ohio Medicaid: review of extreme use and prescribing


43. Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices


44. Questionable billing for compounded topical drugs in Medicare Part D


45. Medicare payments for clinical diagnostic laboratory tests in 2017: year 4 of baseline data


46. Medicare Advantage appeal outcomes and audit findings raise concerns about service and payment denials


47. States follow a common framework in responding to breaches of Medicaid data


48. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters


49. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees


50. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters